Literature DB >> 9630415

Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in a UK burns unit.

M J Weinbren, A P Johnson, M E Kaufmann, D M Livermore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9630415     DOI： 10.1093/jac/41.5.574

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92.

Authors:  H M Donald; W Scaife; S G Amyes; H K Young
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates.

Authors:  G J Da Silva; G J Leitão; L Peixe
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  The increasing role of Acinetobacter species as nosocomial pathogens.

Authors:  Eugénie Bergogne-Bérézin
Journal:  Curr Infect Dis Rep       Date:  2007-10       Impact factor: 3.725

4.  Reliability of Kirby-Bauer disk diffusion method for detecting carbapenem resistance in Acinetobacter baumannii-calcoaceticus complex isolates.

Authors:  Vikas Gautam; Lipika Singhal; Shilpa Arora; Chandana Jha; Pallab Ray
Journal:  Antimicrob Agents Chemother       Date:  2013-04       Impact factor: 5.191

Review 5.  Meropenem: a review of its use in patients in intensive care.

Authors:  M Hurst; H M Lamb
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.